<DOC>
	<DOCNO>NCT01953744</DOCNO>
	<brief_summary>The purpose study evaluate therapeutic response fluconazole patient cutaneous leishmaniasis cause L. ( V. ) guyanensis L. ( V. ) braziliensis .</brief_summary>
	<brief_title>High Dose Fluconazole Cutaneous Leishmaniasis Bahia Manaus</brief_title>
	<detailed_description />
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Leishmaniasis , Cutaneous</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Meglumine antimoniate</mesh_term>
	<criteria>Newly diagnose ( untreated ) cutaneous leishmaniasis localize lesion positive culture diagnose polymerase chain reaction ( PCR ) method intradermal skin testing ( Montenegro test ) . Number lesion : 1 3 ulcerative lesion . LesionÂ´s diameter : 1 5 cm . Disease duration : three month . Evidence serious underlie disease ( cardiac , renal , hepatic pulmonary ) Immunodeficiency antibody HIV Any noncompensated uncontrolled condition , active tuberculosis , malignant disease , severe malaria , HIV , major infectious disease Lactation , pregnancy ( determined adequate test ) inadequate contraception female childbearing potential treatment period plus 2 month Lack suitability trial : Negative parasitology ( aspirate/biopsy/PCR ) negative Montenegro test Any history prior antileishmania therapy Any condition compromise ability comply study procedure Administrative reason : Lack ability willingness give inform consent ( patient and/or parent / legal representative ) Anticipated nonavailability study visits/procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Fluconazole ; Meglumine antimoniate ; L.Braziliensis ;</keyword>
	<keyword>L.Guyanensis</keyword>
</DOC>